On August 27, 2026 (the "Petition Date"), BioXcel Therapeutics, Inc. and two affiliated debtors filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code. The Debtors' bankruptcy cases are pending joint administration under Case No. 26-11360 and are pending before the Honorable Thomas M. Horan in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court").

 

For immediate information about the bankruptcy cases, ask Stretto Conductor.  Additional information about the bankruptcy cases may be obtained by calling the case information line at 833.995.7795 (Toll-Free) and 949.207.7297 (International). You may also submit an inquiry via email by clicking HERE.

Debtors

Case No. Debtor Name
26-11360 BioXcel Therapeutics, Inc.
26-11361 OnkosXcel Employee Holdings, LLC
26-11362 OnkosXcel Therapeutics, LLC

Dates

Petition Date August 27, 2026

First Day Hearing August 31, 2026 (10:00 AM ET)

Meeting of Creditors

Pursuant to section 341 of the Bankruptcy Code, the Meeting of Creditors has been scheduled for September 30, 2026 at 1:00 p.m. and will be held via Zoom.

Meeting ID: 160 0838 5103
Passcode: 4568293370
Call: 1-669-254-5252

Professionals

Proposed Debtors' Counsel COOLEY LLP
YOUNG CONAWAY STARGATT & TAYLOR, LLP

Proposed Debtors' Financial Advisor MERU ADVISORS

Office of the U.S. Trustee UNITED STATES DEPARTMENT OF JUSTICE

Court Information

United States Bankruptcy Court
District of Delaware
824 Market Street North
3rd Floor
Wilmington, DE 19801
Telephone: 302.252.2900